Litcius/Paper detail

Amniotic Fluid Embolism Treated With Inhaled Milrinone: A Case Report

Frederick J. Baxter, Amanda Whippey

2020A&A Practice11 citationsDOI

Abstract

We present a patient with sudden cardiovascular collapse during cesarean delivery that was attributed to amniotic fluid embolism (AFE). The syndrome of AFE may be initiated by an anaphylactoid response to amniotic fluid in the maternal circulation that triggers the release of pulmonary vasoconstrictors, with transient pulmonary vasospasm, causing hemodynamic collapse and profound left ventricular failure. Milrinone, a pulmonary vasodilator used in the management of emergent right ventricular failure, was administered via a nebulizer in an effort to decrease pulmonary vascular resistance. If used immediately after AFE, inhaled milrinone may mitigate pulmonary vasoconstriction, providing a bridge to extracorporeal membrane oxygenation.

Topics & Concepts

MilrinoneMedicineExtracorporeal membrane oxygenationAmniotic fluid embolismAnesthesiaHypoxic pulmonary vasoconstrictionCardiologyPulmonary embolismVasodilationVascular resistanceVasoconstrictionHemodynamicsInternal medicinePregnancyBiologyGeneticsPulmonary Hypertension Research and TreatmentsMaternal and fetal healthcareCardiovascular Issues in Pregnancy